Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors. - Derbala MH; Stephen B; Hwang W; Ock CY; Hwang S; Hajjar J; Lee S; Zhou J; Gurses SA; Gouda MA; McGonagle KE; Alshawa A; et al. (Journal for immunotherapy of cancer, 2026)